rs72687988

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001042413.2(GLIS3):​c.1545G>C​(p.Glu515Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00397 in 1,614,172 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0041 ( 12 hom. )

Consequence

GLIS3
NM_001042413.2 missense

Scores

3
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 3.34

Publications

12 publications found
Variant links:
Genes affected
GLIS3 (HGNC:28510): (GLIS family zinc finger 3) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear protein with five C2H2-type zinc finger domains. This protein functions as both a repressor and activator of transcription and is specifically involved in the development of pancreatic beta cells, the thyroid, eye, liver and kidney. Mutations in this gene have been associated with neonatal diabetes and congenital hypothyroidism (NDH). Alternatively spliced variants that encode different protein isoforms have been described but the full-length nature of only two have been determined. [provided by RefSeq, Jul 2008]
GLIS3 Gene-Disease associations (from GenCC):
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007063985).
BP6
Variant 9-4117933-C-G is Benign according to our data. Variant chr9-4117933-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 196581.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLIS3NM_001042413.2 linkc.1545G>C p.Glu515Asp missense_variant Exon 4 of 11 ENST00000381971.8 NP_001035878.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLIS3ENST00000381971.8 linkc.1545G>C p.Glu515Asp missense_variant Exon 4 of 11 5 NM_001042413.2 ENSP00000371398.3

Frequencies

GnomAD3 genomes
AF:
0.00306
AC:
465
AN:
152202
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00307
Gnomad ASJ
AF:
0.00691
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00132
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00481
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00291
AC:
732
AN:
251376
AF XY:
0.00285
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00194
Gnomad ASJ exome
AF:
0.00853
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00134
Gnomad NFE exome
AF:
0.00432
Gnomad OTH exome
AF:
0.00358
GnomAD4 exome
AF:
0.00407
AC:
5944
AN:
1461852
Hom.:
12
Cov.:
38
AF XY:
0.00406
AC XY:
2949
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.000956
AC:
32
AN:
33480
American (AMR)
AF:
0.00210
AC:
94
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00781
AC:
204
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00104
AC:
90
AN:
86258
European-Finnish (FIN)
AF:
0.00111
AC:
59
AN:
53382
Middle Eastern (MID)
AF:
0.00416
AC:
24
AN:
5768
European-Non Finnish (NFE)
AF:
0.00468
AC:
5203
AN:
1112008
Other (OTH)
AF:
0.00394
AC:
238
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
370
741
1111
1482
1852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00304
AC:
463
AN:
152320
Hom.:
2
Cov.:
31
AF XY:
0.00283
AC XY:
211
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41580
American (AMR)
AF:
0.00307
AC:
47
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00691
AC:
24
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00132
AC:
14
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00481
AC:
327
AN:
68030
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
26
51
77
102
128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00486
Hom.:
3
Bravo
AF:
0.00326
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00500
AC:
43
ExAC
AF:
0.00281
AC:
341
Asia WGS
AF:
0.00144
AC:
6
AN:
3478
EpiCase
AF:
0.00491
EpiControl
AF:
0.00599

ClinVar

Significance: Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Feb 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28444304) -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GLIS3: BS1 -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 28, 2017
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). -

Neonatal diabetes mellitus with congenital hypothyroidism Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.17
CADD
Uncertain
26
DANN
Uncertain
0.98
DEOGEN2
Benign
0.16
T;.
Eigen
Benign
-0.13
Eigen_PC
Benign
0.097
FATHMM_MKL
Benign
0.63
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.0071
T;T
MetaSVM
Benign
-0.36
T
MutationAssessor
Benign
0.41
N;.
PhyloP100
3.3
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.6
N;N
REVEL
Benign
0.24
Sift
Benign
0.38
T;T
Sift4G
Benign
0.32
T;T
Polyphen
0.010
B;B
Vest4
0.28
MutPred
0.40
Gain of phosphorylation at Y356 (P = 0.144);.;
MVP
0.94
MPC
0.15
ClinPred
0.010
T
GERP RS
5.5
Varity_R
0.23
gMVP
0.31
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72687988; hg19: chr9-4117933; COSMIC: COSV60924965; COSMIC: COSV60924965; API